Research Article

[Retracted] Value of 5-Hydroxymethylcytosine in HBV-Carrying High-Risk Hepatocellular Carcinoma Population: An Evaluation Based on Differential Analysis

Figure 5

Receiver operating characteristic curve evaluation of TET3-based 5hmC prediction model. (a) Training set (, , 95% CI: 0.729-0.893). (b) Validation set (, , 95% CI: 0.739-0.936). AUC: area under curve; 95% CI: 95% confidence interval.
(a)
(b)